FDA Bans CFC Inhalers, Walmart Offers Low-Cost Alternative
An FDA mandate that came into effect on Dec. 31 dictates that all albuterol metered-dose asthma inhalers marketed in the U.S. must use hydrofluroalkane (HFA) propellants, as opposed to chlorofluorocarbon (CFC) propellants.
Most manufacturers, like GlaxoSmithKline (GSK) and Schering-Plough, hurried to make the transition and have increased production to ensure an adequate supply of HFA inhalers. Armstrong Pharmaceuticals has not yet done so, the FDA said.
Rescue inhalers can be costly: some HFA inhalers may sell for as much as $60 for certain brands. To make the life-saving medication affordable, Walmart is going to sell the ReliOn Ventolin HFA inhaler for $9.
Energy Manager News
- Making the IoT Work for Building Managers
- There’s Nothing More Sacred Than Coal in Coal Country. Ask Hillary Clinton
- SunPower and the Army Work on Solar Project in Alabama
- Climate and Energy Policies Working
- ERC: Price Benchmark Trends Week Ending April 29, 2016
- Xcel Energy Files to Refund $15M to Colorado Electric Customers
- New Retail Marketplace, MassEnergyRates.com, Launches in the Bay State
- Will Utilities Lease Rooftops of Commercial Buildings for Solar Power Generation?